Lomonosov Moscow State University

Nindanib 150 (Nintedanibe 150 mg): A Breakthrough in Pulmonary Fibrosis Treatment Introduction: Pulmonary fibrosis is a serious and debilitating lung disease that affects millions of people worldwide. It is characterized by the scarring and thickening of the lung tissue, which can lead to difficulty breathing and decreased lung function. Patients w

read more